23andMe Holding Co. ME:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/24/22 EDT
2.78UNCH (UNCH)
Volume
1,110,890
Close
2.78quote price arrow up+0.05 (+1.83%)
Volume
21,845,794
52 week range
2.12 - 13.68
Loading...
  • Open2.80
  • Day High2.91
  • Day Low2.75
  • Prev Close2.73
  • 52 Week High13.68
  • 52 Week High Date11/08/21
  • 52 Week Low2.12
  • 52 Week Low Date06/13/22

Key Stats

  • Market Cap1.249B
  • Shares Out449.17M
  • 10 Day Average Volume4.62M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-58.26

KEY STATS

  • Open2.80
  • Day High2.91
  • Day Low2.75
  • Prev Close2.73
  • 52 Week High13.68
  • 52 Week High Date11/08/21
  • 52 Week Low2.12
  • 52 Week Low Date06/13/22
  • Market Cap1.249B
  • Shares Out449.17M
  • 10 Day Average Volume4.62M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-58.26

RATIOS/PROFITABILITY

  • EPS (TTM)-0.60
  • P/E (TTM)-4.62
  • Fwd P/E (NTM)-4.25
  • EBITDA (TTM)-227.574M
  • ROE (TTM)-
  • Revenue (TTM)271.89M
  • Gross Margin (TTM)48.90%
  • Net Margin (TTM)-79.99%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/18/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On 23andMe Holding Co.

Profile

MORE
23andMe Holding Co. is a genetics-led consumer healthcare and therapeutics company. The Company's segments include Consumer & Research Services and Therapeutics. The Consumer & Research Services segment comprises its Personal Genome Service (PGS), telehealth business, and research services. Its PGS service provides customers with a suite of genetic reports, including information on customers genetic ancestral origins, personal genetic health risks, and chances of passing on...
Address
349 Oyster Point Boulevard
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
MYOV
Myovant Sciences Ltd
13.26-0.51-3.70%
VCYT
Veracyte Inc
22.74+0.92+4.22%
LGND
Ligand Pharmaceuticals Inc
89.30+1.49+1.70%
PRTA
Prothena Corporation PLC
27.77+0.23+0.84%
FGEN
FibroGen Inc
11.62-0.09-0.77%